{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:12:21Z","timestamp":1776147141257,"version":"3.50.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Ovarian cancer (OC) is a major clinical problem in gynaecological oncology, characterised by difficulties in early diagnosis, which contributes to the high mortality rate from OC. Therefore, the search for new biological markers continues, which could complement the diagnostic process in the future and potentially improve patient prognosis. Recently, the role of adipokines and accompanying inflammation in carcinogenesis mechanisms, including within the ovary, has become a subject of scientific interest. The aim of this study was to determine the concentrations of irisin, chemerin, lipocalin-2 and omentin-1 in the serum and peritoneal fluid of patients with ovarian cancer, as well as in the serum of patients with benign ovarian lesions. The analysis showed differences in the concentrations of these molecules between the study groups. Certain correlations were also observed between the levels of selected adipokines and the degree of histological differentiation of the tumour. The observed immune disorders associated with adipokine profiles suggest that they may be involved in the immunopathogenesis of ovarian cancer, acting as one of the factors modulating the inflammatory environment of the tumour. From a clinical point of view, the potential application of measuring the concentrations of these adipokines \u2013 for example, in combination with known markers such as CRP or CA125 \u2013 increases diagnostic effectiveness compared to single measurement of these parameters, but requires further verification. At this stage, they can only serve as a starting point for discussion on new diagnostic methods.<\/jats:p>","DOI":"10.3389\/fonc.2026.1757624","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:36:40Z","timestamp":1776145000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The potential clinical significance of immunomodulation of immune and inflammatory responses involving selected adipokines in patients with ovarian cancer \u2013 preliminary studies"],"prefix":"10.3389","volume":"16","author":[{"given":"Sebastian","family":"St\u0119pie\u0144","sequence":"first","affiliation":[{"name":"Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Laura","family":"Morawiec","sequence":"additional","affiliation":[{"name":"Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Smycz-Kuba\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Witek","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Mielczarek-Palacz","sequence":"additional","affiliation":[{"name":"Department of Immunology and Serology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia","place":["Katowice, Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11040697","article-title":"What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 World Health Organization classification of female genital tumors","volume":"11","author":"De Leo","year":"2021","journal-title":"Diagnostics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1858","article-title":"Omentum provides a special cell microenvironment for ovarian cancer","volume":"6","author":"Li","year":"2023","journal-title":"Cancer Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111180","article-title":"CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1","volume":"119","author":"Geng","year":"2024","journal-title":"Cell Signalling"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01660-y","article-title":"Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021","volume":"18","author":"Li","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2025.05.013","article-title":"The intricate role of adipokines in cancer-related signaling and the tumor microenvironment: Insights for future research","volume":"113","author":"Kounatidis","year":"2025","journal-title":"Semin Cancer Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.62347\/XZRI9189","article-title":"Cancer-associated adipocytes in the ovarian cancer microenvironment","volume":"14","author":"Cai","year":"2024","journal-title":"Am J Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3892\/mmr.2021.12506","article-title":"Multi-faceted role of cancer-associated adipocytes in the tumor microenvironment (review)","volume":"24","author":"Yao","year":"2021","journal-title":"Mol Med Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.03.027","article-title":"Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment","volume":"86","author":"Schoutrop","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081118","article-title":"The role of selected adipocytokines in ovarian cancer and endometrial cancer","volume":"12","author":"St\u0119pie\u0144","year":"2023","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.685923","article-title":"Targeting adipokines in obesity-related tumors","volume":"11","author":"Pu","year":"2021","journal-title":"Front Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051857","article-title":"A novel insight into the role of obesity-related adipokines in ovarian cancer\u2014state-of-the-art review and future perspectives","volume":"26","author":"Ko\u0142akowska","year":"2025","journal-title":"IJMS"},{"key":"B16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13048-020-00718-4","article-title":"Adipocytes: Active facilitators in epithelial ovarian cancer progression","volume":"13","author":"Dai","year":"2020","journal-title":"J Ovarian Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194778","article-title":"More than an adipokine: The complex roles of chemerin signaling in cancer","volume":"20","author":"Goralski","year":"2019","journal-title":"IJMS"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1738","article-title":"Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer","volume":"5","author":"Candido","year":"2014","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061479","article-title":"The role of irisin in cancer disease","volume":"10","author":"Pinkowska","year":"2021","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1038\/s41467-020-17383-2","article-title":"ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment","volume":"11","author":"Au-Yeung","year":"2020","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.962968","article-title":"Role of irisin in physiology and pathology","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bbrc.2016.12.084","article-title":"Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition","volume":"485","author":"Shao","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S214260","article-title":"Irisin functions to inhibit Malignant growth of human pancreatic cancer cells via downregulation of the PI3K\/AKT signaling pathway","volume":"12","author":"Zhang","year":"2019","journal-title":"OTT"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5973","article-title":"Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3\/Snail signaling pathway","volume":"38","author":"Kong","year":"2017","journal-title":"Oncol Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae181","article-title":"Chemerin in immunity","volume":"117","author":"Laffranchi","year":"2025","journal-title":"J Leukocyte Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153750","article-title":"Chemerin and cancer","volume":"20","author":"Treeck","year":"2019","journal-title":"IJMS"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081910","article-title":"Chemerin: A functional adipokine in reproductive health and diseases","volume":"10","author":"Yu","year":"2022","journal-title":"Biomedicines"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-016-1846-8","article-title":"Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions","volume":"21","author":"Ghallab","year":"2017","journal-title":"Clin Oral Invest"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2018.0006","article-title":"St\u0119\u017cenia adipokin u m\u0119\u017cczyzn z rakiem prostaty i z \u0142agodnym przerostem prostaty","author":"Siemi\u0144ska","year":"2015","journal-title":"Endokrynologia Polska"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112124","article-title":"The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses","volume":"209","author":"Pachynski","year":"2012","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5301\/jbm.5000245","article-title":"Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? A systematic review of current evidence","volume":"32","author":"Roli","year":"2017","journal-title":"Int J Biol Markers"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10090336","article-title":"Revisiting neutrophil gelatinase-associated lipocalin (NGAL) in cancer: Saint or sinner","volume":"10","author":"Bauvois","year":"2018","journal-title":"Cancers"},{"key":"B33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12094-021-02666-x","article-title":"Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis","volume":"24","author":"Lei","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.58789","article-title":"Elevated plasma level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with breast cancer","volume":"18","author":"Wei","year":"2021","journal-title":"Int J Med Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jbior.2018.05.002","article-title":"Roles of P53, NF-\u03baB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines","volume":"69","author":"Chappell","year":"2018","journal-title":"Adv Biol Regul"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6589262","article-title":"Clinical relevance of NGAL\/MMP-9 pathway in patients with endometrial cancer","volume":"2017","author":"Cymbaluk-P\u0142oska","year":"2017","journal-title":"Dis Markers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/sjmms.sjmms_581_21","article-title":"NGAL\/MMP-9 as a biomarker for epithelial ovarian cancer: A case\u2013control diagnostic accuracy study","volume":"10","author":"Gupta","year":"2022","journal-title":"Saudi J Med Med Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22352","article-title":"Neutrophil gelatinase\u2010associated lipocalin (NGAL) an early\u2010screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor\u2010induced epithelio\u2010mesenchymal transition","volume":"120","author":"Lim","year":"2007","journal-title":"Intl J Cancer"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902683R","article-title":"LncRNA TMPO\u2010AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer","volume":"34","author":"Zhao","year":"2020","journal-title":"FASEB J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.2009.953257","article-title":"Lipocalin 2 expressions correlate significantly with tumor differentiation in epithelial ovarian cancer","volume":"57","author":"Cho","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.15171\/apb.2020.013","article-title":"Association of omentin-1 with oxidative stress and clinical significances in patients with breast cancer","volume":"10","author":"Tahmasebpour","year":"2019","journal-title":"Adv Pharm Bull"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5971981","article-title":"Diagnostic and prognostic role of serum omentin and NGAL levels in Egyptian breast cancer patients","volume":"2022","author":"Abas","year":"2022","journal-title":"Int J Breast Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-2836","article-title":"Analysis of the expression of plasma omentin-1 level in colorectal cancer and its correlation with prognosis","volume":"9","author":"Feng","year":"2020","journal-title":"Transl Cancer Res TCR"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041179","article-title":"Serum omentin levels in patients with prostate cancer and associations with sex steroids and metabolic syndrome","volume":"9","author":"Borowski","year":"2020","journal-title":"JCM"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S197507","article-title":"Altered circulating levels of adipokine omentin-1 in patients with prostate cancer","volume":"12","author":"Zhou","year":"2019","journal-title":"OTT"},{"key":"B46","first-page":"77","article-title":"Serum omentin-1 and chemerin concentrations in pancreatic cancer and chronic pancreatitis","volume":"58","author":"Kiczmer","year":"2018","journal-title":"Folia Med Cracov"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020275","article-title":"Role of omentin in obesity paradox in lung cancer","volume":"13","author":"Parida","year":"2021","journal-title":"Cancers"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231912041","article-title":"Molecular biomarkers for the early detection of ovarian cancer","volume":"23","author":"Zhang","year":"2022","journal-title":"IJMS"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1001\/jama.2025.9495","article-title":"Ovarian cancer: A review","volume":"334","author":"Caruso","year":"2025","journal-title":"JAMA"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104611","article-title":"Ovarian cancer\u2014epidemiology, classification, pathogenesis, treatment, and estrogen receptors\u2019 molecular backgrounds","volume":"26","author":"Smolarz","year":"2025","journal-title":"IJMS"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06427-1","article-title":"Irisin\/FNDC5 inhibits the epithelial\u2013mesenchymal transition of epithelial ovarian cancer cells via the PI3K\/Akt pathway","volume":"306","author":"Zhu","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1835\u2013","DOI":"10.1007\/s00404-022-06770-3","article-title":"Correction to: Irisin\/FNDC5 inhibits the epithelial\u2013mesenchymal transition of epithelial ovarian cancer cells via the PI3K\/Akt pathway","volume":"306","author":"Zhu","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"B53","article-title":"Irisin immunostaining characteristics of breast and ovarian cancer cells","volume":"62","author":"Kuloglu","year":"2016","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26700-2","article-title":"Effects of the exercise-inducible myokine irisin on proliferation and Malignant properties of ovarian cancer cells through the HIF-1 \u03b1 signaling pathway","volume":"13","author":"Alizadeh Zarei","year":"2023","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2100392","article-title":"Chemerin promotes proliferation and migration of ovarian cancer cells by upregulating expression of PD-L1","volume":"23","author":"Gao","year":"2022","journal-title":"J Zhejiang Univ-Sci B"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13050944","article-title":"Chemerin and chemokine-like receptor 1 expression in ovarian cancer associates with proteins involved in estrogen signaling","volume":"13","author":"Weber","year":"2023","journal-title":"Diagnostics"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040991","article-title":"Active forms of chemerin are elevated in human and mouse ovarian carcinoma","volume":"13","author":"Zhao","year":"2025","journal-title":"Biomedicines"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/7957018","article-title":"Chemerin enhances migration and invasion of OC cells via CMKLR1\/RhoA\/ROCK\u2010mediated EMT","volume":"2024","author":"Sun","year":"2024","journal-title":"Int J Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174108","article-title":"Anti-tumoral effect of chemerin on ovarian cancer cell lines mediated by activation of interferon alpha response","volume":"14","author":"Schmitt","year":"2022","journal-title":"Cancers"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124365","article-title":"Biological functions and therapeutic potential of lipocalin 2 in cancer","volume":"21","author":"Santiago-S\u00e1nchez","year":"2020","journal-title":"IJMS"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1757624\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:36:41Z","timestamp":1776145001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1757624\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":60,"alternative-id":["10.3389\/fonc.2026.1757624"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1757624","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"article-number":"1757624"}}